Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
XBB.6.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BF.21NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
FK.1.3.2NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
XBFNSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BA.5.6NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BF.11.5NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
XBF.7.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.1.367NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
GK.1.9NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BN.1.3.13NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.385NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
XBB.1.5.45NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.1.244NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
JD.2.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
EP.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
FL.17.2NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
EG.12NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
XBB.2.3.18NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
XBC.1.6.5NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
FL.39NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.1.141NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.591NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.468NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
AY.131 (Delta)NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.586NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.366NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.1.380NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
XBB.1.5.100NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
XBB.1.16.19NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
XBB.1.43.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
EU.1.1.3NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
XBB.1.5.18NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
XBB.1.5.48NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
XBB.1.5.10NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
EK.2.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
XBB.1.5.2NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
XBB.1.5.66NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
XDHNSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
FL.15.2NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
EG.2.2NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
XBB.1.16.32NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.1.273NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
AY.4.13 (Delta)NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.1.358NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
C.28NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.177.60NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.1.159NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.625NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
HD.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
GY.4NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used